Injective (INJ) has shown a bullish breakout after a period of consolidation, with analysts noting the formation of higher lows signaling a potential trend reversal. At press time, INJ was trading at $6.63, down 2.84% on the day. The project’s long-term outlook is bolstered by the proposed Vulcan Mainnet upgrade, which aims to enhance real-world asset integration and on-chain trading infrastructure.
The cryptocurrency Injective (INJ) is exhibiting a bullish breakout following a consolidation phase, suggesting a possible trend reversal. Its price structure remains positive above key support levels, with the first major resistance target seen near $16.
At the time of writing, INJ was trading at $6.63 with a 24-hour trading volume of approximately $229.7 million. The asset’s market capitalization stands at around $662.9 million, despite a recent 2.84% decline.
Analyst CryptoBoss stated that Injective is showing a familiar market structure where tight consolidation often precedes strong directional moves. “After compressing within a defined channel, the Injective price has now broken above resistance and is beginning to print higher weekly lows,” the analyst noted.
Technical indicators from TradingView show the price trading above all key Exponential Moving Averages, with the 20 EMA at $5.64 acting as support. The 14-day Relative Strength Index (RSI) is at 69.99, nearing overbought territory after a rapid ascent from a low near $2.85 in mid-April.
The network’s development team has proposed the Vulcan Mainnet upgrade to strengthen its position in perpetual markets and real-world assets. This upgrade focuses on improving infrastructure, performance, and financial primitives for a unified on-chain trading experience.
